Page 1 | Search Results | Blood | American Society of Hematology

1-16 of 16

Sort by

Sort Order Select

Journal Articles

HM43239, a Novel Small Molecule Inhibitor of FLT3, in Acute Myeloid Leukemia (AML) with and without FMS-like Tyrosine Kinase 3 (FLT3) Mutations: Phase 1/2 Study

Naval Daver, MD, Kyoo Hyung Lee, MD PhD, Chul Won Jung, MD PhD, Yoon Sung Soo, MD PhD, Martha L. Arellano, MD, Brian A Jonas, MD PhD, Jiyeon Yoon, PhD, Sooa Jung, PhD, Young Su Noh, PhD, Inhwan Bae, PhD, Song Kim, MD

Blood (2020) 136 (Supplement 1): 1.

https://doi.org/10.1182/blood-2020-143244

Published: 2020

Journal Articles

HM43239, a Novel Potent Small Molecule FLT3 Inhibitor, in Acute Myeloid Leukemia (AML) with FMS-like Tyrosine Kinase 3 (FLT3) Mutations: Phase 1 /2 Study

Naval G. Daver, MD, Kyoo Hyung Lee, MD PhD, Sung-Soo Yoon, MD PhD, Chul Won Jung, MD PhD, Hyun Jeong Kang, Sooa Jung, Sujin Seo, Jiyeon Yoon, Hyunjin Kim, Young Su Noh, Yoonha Seo, Hyeyoung Kwon, Oakpil Han, Seungjae Baek, MD PhD, Kyounghee Seo, Kwee Hyun Suh, PhD

Blood (2019) 134 (Supplement_1): 1331.

https://doi.org/10.1182/blood-2019-129670

Published: 2019

Journal Articles

Clinical Relevance of Diagnostic Criteria for Hemophagocytic Lymphohistiocytosis (HLH) and Survival Outcome of Adult HLH Patients: A Single-Center Prospective Cohort Study

Joon Young Hur, MD, Kang Kook Lee, MD, Jun Ho Jang, MD PhD, Kihyun Kim, MD PhD, Chul Won Jung, MD PhD, Won Seog Kim, MD PhD, Seok Jin Kim, MD PhD

Blood (2018) 132 (Supplement 1): 3718.

https://doi.org/10.1182/blood-2018-99-114858

Published: 2018

Journal Articles

Bortezomib-Based First Line Treatment for AL Amyloidosis Patients Who Are Not Candidate for Stem Cell Transplantaion

Joon Young Hur, MD, Kang Kook Lee, MD, Sang Eun Yoon, MD, Sehhoon Park, MD, Jangho Cho, MD, Youjin Kim, MD, Eunseok Jeon, MD PhD, Jinoh Choi, MD PhD, Gayeon Lee, MD PhD, Byungjun Kim, MD PhD, Ju Hong Min, MD PhD, Jung Sun Kim, MD PhD, Jung Eun Lee, MD PhD, Joon Young Choi, MD PhD, Seok Jin Kim, MD PhD, Jun Ho Jang, MD PhD, Won-Seog Kim, MD PhD, Chul Won Jung, MD PhD, Kihyun Kim, MD PhD

Blood (2018) 132 (Supplement 1): 3256.

https://doi.org/10.1182/blood-2018-99-114099

Published: 2018

Journal Articles

Killer Cell Immunoglobulin-like Receptor Ligand Matching Determines the Post-Transplant High Risk Groups Among Patients with Permissive HLA Mismatch in Unrelated Donor Hematopoietic Cell Transplantation

Yoo Jin Lee, MD, Joon Ho Moon, MD, PhD, In Hee Lee, MD, Jae-Ho Yoon, Byung-Sik Cho, Jae-Sook Ahn, MD PhD, Hyeoung Joon Kim, MD PhD, Silvia Park, Jun Ho Jang, MD PhD, Chul Won Jung, MD PhD, Hyunsung Park, MD, June-Won Cheong, MD, Je-Hwan Lee, MD PhD, Sang Kyun Sohn, MD, PhD, Hee-Je Kim

Blood (2016) 128 (22): 4566.

https://doi.org/10.1182/blood.V128.22.4566.4566

Published: 2016

Journal Articles

Genome-Wide Genotype-Based Risk Model for Survival in Core Binding Factor Acute Myeloid Leukemia Patients

Silvia Park, Choi Hangseok, Hee-Je Kim, Jae-Sook Ahn, Hyeoung Joon Kim, MD PhD, Sung-Hyun Kim, Yeung-Chul Mun, Chul Won Jung, MD PhD, Dong Hwan Kim, MD PhD

Blood (2016) 128 (22): 1623.

https://doi.org/10.1182/blood.V128.22.1623.1623

Published: 2016

Journal Articles

Randomized Trial of Micafungin Versus Fluconazole in Prophylaxis Against Invasive Fungal Infections in Hematopoietic Stem Cell Transplant Recipients

Silvia Park, MD, Kihyun Kim, Jun Ho Jang, MD PhD, Seok Jin Kim, MDPhD, Won Seog Kim, MD PhD, Chul Won Jung, MD PhD, Ki Sun Jung, Jinhyun Cho, Kwai Han Yoo, MD, Haa-na Song

Blood (2015) 126 (23): 1904.

https://doi.org/10.1182/blood.V126.23.1904.1904

Published: 2015

Journal Articles

Survey of Qol (quality of life) on Patients Receiving Tyrosine Kinase Inhibitors for Chronic Myeloid Leukemia: Korean CML Working Party Group

Kyoung Ha Kim, Dae-Young Kim, MD PhD, Sung-Hyun Kim, Yeo-Kyeoung Kim, Inho Kim, Hee-Jin Kim, MD PhD, Sang Kyun Sohn, MD PhD, Jeon-Ok Lee, June-Won Cheong, MD, PhD, Chul Won Jung, MD PhD, Young-Uk Cho, MD PhD

Blood (2015) 126 (23): 5166.

https://doi.org/10.1182/blood.V126.23.5166.5166

Published: 2015

Journal Articles

5-Hydroxymethylcytosine Is Correlated with TET2 or IDH1/2 Mutations However, May Not be a Prognostic Value to Predict the Survivals in Normal Karyotype AML

Jae-Sook Ahn, MDPhD, Hyeoung-Joon Kim, MD PhD, Yeo-Kyeoung Kim, MD, PhD, Seung-Shin Lee, MD, Sung-Hoon Jung, MD PhD, Deok-Hwan Yang, MD PhD, Je-Jung Lee, Park Hee Jeong, Seung Hyun Choi, PhD, Chul Won Jung, MD PhD, Jun-Ho Jang, MD PhD, Heeje Kim, MD PhD, Joon Ho Moon, MD, PhD, Sang Kyun Sohn, MD PhD, Sung-Hyun Kim, Dennis Dong Hwan Kim, MD PhD

Blood (2015) 126 (23): 3832.

https://doi.org/10.1182/blood.V126.23.3832.3832

Published: 2015

Journal Articles

A Prospective Randomized Comparison of Cyclophosphamide Versus Fludarabine in Addition of Antithymocyte Globuline for Allogeneic Hematopoietic Cell Transplantation in Patients with Adult Severe Aplastic Anemia; Interim Analysis

Hawk Kim, MD, PhD., Won-Sik Lee, Yeo-Kyeoung Kim, MD PhD, Young-Don Joo, Jinny Park, MD PhD, Chul Won Jung, MD PhD, Jae-Cheol Jo, Jung-Hee Lee, MD PhD, Je-Hwan Lee, MD PhD, Dae-Young Kim, MD, Kyoo-Hyung Lee, MD

Blood (2014) 124 (21): 3890.

https://doi.org/10.1182/blood.V124.21.3890.3890

Published: 2014

Journal Articles

Treatment Outcome and Prognostic Factors of Korean Patients with Chronic Lymphocytic Leukemia: Multicenter Retrospective Study

Yunsuk Choi, MD PhD, Jung-Hee Lee, MD PhD, Chul Won Jung, MD PhD, Jin Seok Kim, Inho Kim, MD PhD, Silvia Park, MD, June-Won Cheong, MD, PhD, Seonyang Park, MD PhD, Sung-Yong Kim, Mark Hong Lee, MD PhD

Blood (2014) 124 (21): 5669.

https://doi.org/10.1182/blood.V124.21.5669.5669

Published: 2014

Journal Articles

An Adverse Prognostic Effect of Homozygous TET2 Mutational Status on the Relapse Risk of Acute Myeloid Leukemia Patients of Normal Karyotype

Jae-Sook Ahn, MDPhD, Hyeoung-Joon Kim, MD PhD, Yeo-Kyeoung Kim, MD, PhD, Il-Kwon Lee, PhD, Nan Young Kim, Mark D Minden, MDPhD, Chul Won Jung, MD PhD, Jun-Ho Jang, MD PhD, Hee-Je Kim, Joon Ho Moon, MD, PhD, Sang Kyun Sohn, MD PhD, Jong-Ho Won, Sung-Hyun Kim, MD PhD, Namshin Kim, PhD, Kenichi Yoshida, MD PhD, Seishi Ogawa, MD PhD, Dennis Dong Hwan Kim, MDPhD

Blood (2014) 124 (21): 1052.

https://doi.org/10.1182/blood.V124.21.1052.1052

Published: 2014

Journal Articles

A Multinational, Open-Label Phase 2 Study Of Ruxolitinib In Asian Patients (Pts) With Primary Myelofibrosis (PMF), Post–Polycythemia Vera MF (PPV-MF), Or Post–Essential Thrombocythemia MF (PET-MF)

Chul Won Jung, MD, PhD, Lee-Yung Shih, MD, Zhijian Xiao, MD, Jie Jin, MD, Hsin-An Hou, MD, Xin Du, MD, Ming-Chung Wang, MD, Seonyang Park, MD, PhD, Ki-Seong Eom, MD, PhD, Kenji Oritani, Shinichiro Okamoto, MD, PhD, Tetsuzo Tauchi, MD, Jin Seok Kim, MD, Daobin Zhou, MD, Andres Sirulnik, MD, PhD, Wanda Ruiz, PhD, Taro Amagasaki, PhD, Kazuo Ito, Koichi Akashi, MD, PhD

Blood (2013) 122 (21): 4086.

https://doi.org/10.1182/blood.V122.21.4086.4086

Published: 2013

Journal Articles

Incidence Of VTE Following Genitourinary Surgery In Korea and Evidence-Based Korean Guidelines For Preventing VTE In Patients Undergoing Genitourinary Surgery

Yeo-Kyeoung Kim, MD, PhD, Soo-Mee Bang, MD, PhD, Moon Ju Jang, MD, PhD, Ho-Young Yhim, MD, PhD, Won-Il Choi, MD, PhD, Kyoung Ha Kim, MD, PhD, Sung Hwa Bae, Yang-Ki Kim, MD, PhD, Seung-Hyun Nam, MD, PhD, Sung-Hyun Kim, MD, PhD, Yeung-Chul Mun, Inho Kim, Chul Won Jung, MD, PhD, Doyeun Oh, MD, PhD

Blood (2013) 122 (21): 1138.

https://doi.org/10.1182/blood.V122.21.1138.1138

Published: 2013

Journal Articles

NPM1, IDH1/2 and DNAH11 Gene Mutations Can Improve a Prognostic Stratification of Acute Myeloid Leukemia Patients with Normal Karyotype but Not Harboring FLT3/ITD Mutation.

Yeo-Kyeoung Kim, MD, PhD, Il-Kwon Lee, PhD, Dennis Dong Hwan Kim, MD, PhD, Chul Won Jung, MD, PhD, Jun-Ho Jang, MD, PhD, Hee Je Kim, MD, PhD, Joon Ho Moon, MD, Sang Kyun Sohn, MD, Jong-Ho Won, MD, PhD, Sung-Hyun Kim, Jungwon Huh, MD, PhD, Namshin Kim, PhD, Yun Gyeong Lee, PhD, Sung-Hoon Jung, MD, Je-Jung Lee, MD, PhD, Hyeoung-Joon Kim, MD, PhD

Blood (2012) 120 (21): 2534.

https://doi.org/10.1182/blood.V120.21.2534.2534

Published: 2012

Journal Articles

Efficacy and Safety of Micafungin as An Empirical Antifungal Agent for Febrile Neutropenic Patients with Hematological Diseases.

Joon Seong Park, MD, Dong Hwan Kim, MD, PhD, Chul Won Choi, MD, PhD, Seong Hyun Jeong, MD, Jin-Hyuk Choi, MD, PhD, Kihyun Kim, MD, PhD, Seok Jin Kim, MD, PhD, Chul Won Jung, MD, PhD, Deok-Hwan Yang, MD, Hugh Chul Kim, MD, Jun Ho Jang, MD, PhD

Blood (2009) 114 (22): 4661.

https://doi.org/10.1182/blood.V114.22.4661.4661

Published: 2009

NARROW

HM43239, a Novel Small Molecule Inhibitor of FLT3, in Acute Myeloid Leukemia (AML) with and without FMS-like Tyrosine Kinase 3 (FLT3) Mutations: Phase 1/2 Study

HM43239, a Novel Potent Small Molecule FLT3 Inhibitor, in Acute Myeloid Leukemia (AML) with FMS-like Tyrosine Kinase 3 (FLT3) Mutations: Phase 1 /2 Study

Clinical Relevance of Diagnostic Criteria for Hemophagocytic Lymphohistiocytosis (HLH) and Survival Outcome of Adult HLH Patients: A Single-Center Prospective Cohort Study

Bortezomib-Based First Line Treatment for AL Amyloidosis Patients Who Are Not Candidate for Stem Cell Transplantaion

Killer Cell Immunoglobulin-like Receptor Ligand Matching Determines the Post-Transplant High Risk Groups Among Patients with Permissive HLA Mismatch in Unrelated Donor Hematopoietic Cell Transplantation

Genome-Wide Genotype-Based Risk Model for Survival in Core Binding Factor Acute Myeloid Leukemia Patients

Randomized Trial of Micafungin Versus Fluconazole in Prophylaxis Against Invasive Fungal Infections in Hematopoietic Stem Cell Transplant Recipients

Survey of Qol (quality of life) on Patients Receiving Tyrosine Kinase Inhibitors for Chronic Myeloid Leukemia: Korean CML Working Party Group

5-Hydroxymethylcytosine Is Correlated with TET2 or IDH1/2 Mutations However, May Not be a Prognostic Value to Predict the Survivals in Normal Karyotype AML

A Prospective Randomized Comparison of Cyclophosphamide Versus Fludarabine in Addition of Antithymocyte Globuline for Allogeneic Hematopoietic Cell Transplantation in Patients with Adult Severe Aplastic Anemia; Interim Analysis

Treatment Outcome and Prognostic Factors of Korean Patients with Chronic Lymphocytic Leukemia: Multicenter Retrospective Study

An Adverse Prognostic Effect of Homozygous TET2 Mutational Status on the Relapse Risk of Acute Myeloid Leukemia Patients of Normal Karyotype

A Multinational, Open-Label Phase 2 Study Of Ruxolitinib In Asian Patients (Pts) With Primary Myelofibrosis (PMF), Post–Polycythemia Vera MF (PPV-MF), Or Post–Essential Thrombocythemia MF (PET-MF)

Incidence Of VTE Following Genitourinary Surgery In Korea and Evidence-Based Korean Guidelines For Preventing VTE In Patients Undergoing Genitourinary Surgery

NPM1, IDH1/2 and DNAH11 Gene Mutations Can Improve a Prognostic Stratification of Acute Myeloid Leukemia Patients with Normal Karyotype but Not Harboring FLT3/ITD Mutation.

Efficacy and Safety of Micafungin as An Empirical Antifungal Agent for Febrile Neutropenic Patients with Hematological Diseases.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only